Access Resources
Thank you for your interest in our resources. Please fill out the information here to have full access to our library of useful information, including what you are looking for currently.
By submitting this data form, you consent to WuXi AppTec collecting and processing the information you provided for our internal use, in accordance with our Privacy Policy.
← Return to ResourcesRelated Content
Glucagon‐like peptide‐1 (GLP-1) receptor agonists have emerged as promising therapeutic options for addressing type‐2 diabetes, obesity, and related conditions. However,...
VIEW RESOURCELeverage our extensive panel of rat xenograft and syngeneic tumor models. Advantages for using rats in preclinical efficacy studies compared...
VIEW RESOURCE